🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Eisai GmbH — Licensed Medicines

15 medicines held by Eisai GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 15 products held by Eisai GmbH
MedicineActive substanceLicence holderStatus
Fycompa 0.5 mg film-coated tablets
EU/1/12/776/024
Perampanel Eisai GmbH
Fycompa 10 mg film-coated tablets
EU/1/12/776/011-013
Perampanel Eisai GmbH
Fycompa 12 mg film-coated tablets
EU/1/12/776/014-016
Perampanel Eisai GmbH
Fycompa 2 mg film-coated tablets
EU/1/12/776/001
Perampanel Eisai GmbH
Fycompa 4 mg film-coated tablets
EU/1/12/776/002-004
Perampanel Eisai GmbH
Fycompa 6 mg film-coated tablets
EU/1/12/776/005-007
Perampanel Eisai GmbH
Fycompa 8 mg film-coated tablets
EU/1/12/776/008-010
Perampanel Eisai GmbH
HALAVEN 0.44 mg/ml solution for injection
EU/1/11/678/001-002
Eribulin mesylate Eisai GmbH
Inovelon
EU/1/06/378/1-16
Rufinamide Eisai GmbH
Inovelon 40 mg/ml oral suspension
EU/1/06/378/017
Rufinamide Eisai GmbH
Kisplyx 10 mg hard capsules
EU/1/16/1128/002
Lenvatinib mesilate Eisai GmbH
Kisplyx 4 mg hard capsules
EU/1/16/1128/001
Lenvatinib mesilate Eisai GmbH
LENVIMA 10 mg hard capsules
EU/1/15/1002/002
Lenvatinib mesylate Eisai GmbH
LENVIMA 4 mg hard capsules
EU/1/15/1002/001
Lenvatinib mesylate Eisai GmbH
LEQEMBI 100 mg/mL concentrate for solution for infusion
EU/1/24/1891/001-002
Lecanemab Eisai GmbH
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.